https://salthill-group.com/publication-in-lancet-eclinicalmedicine-detailing-the-arcadia-clinical-trial/2025-11-07T10:55:25+00:00https://salthill-group.com/st-george-street-capital-sgsc-and-excalibur-medicines-limited-eml-are-pleased-to-provide-an-update-on-the-positive-outcome-of-the-arcadia-covid-19-therapy-trial/2025-11-07T10:55:25+00:00https://salthill-group.com/clinical-study-report-on-therapy-to-treat-covid-19-patients-completed-issued-on-behalf-of-st-george-street-capital-and-excalibur-medicines-ltd/2025-11-07T10:55:25+00:00https://salthill-group.com/investors-back-potential-drug-for-diabetic-covid-19-patients/2025-11-07T10:55:25+00:00https://salthill-group.com/update-re-st-george-street-capital-covid-19-trial-company-announcement-ft-com/2025-11-07T10:55:25+00:00https://salthill-group.com/promising-early-results-reported-for-treatment-designed-to-help-people-with-diabetes-recover-from-effects-of-coronavirus/2025-11-07T10:55:24+00:00https://salthill-group.com/arcadia-clinical-trial-of-new-therapeutic-for-treatment-of-covid-19-in-diabetes-sufferers-passes-key-milestone-hub-publishing/2025-11-07T10:55:24+00:00https://salthill-group.com/results-from-arcadia-phase-ii-clinical-trial-of-a-potential-therapy-for-covid-19/2025-11-07T10:55:24+00:00https://salthill-group.com/outstanding-clinical-practitioner-award/2025-11-07T10:55:24+00:00https://salthill-group.com/salt-hill-agrees-exclusive-patent-license-from-queen-mary-university-of-london-to-advance-novel-treg-activation-technology/2025-11-07T10:55:24+00:00